Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly
- 22 December 1986
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 81 (6) , 94-101
- https://doi.org/10.1016/0002-9343(86)90590-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- RAPID IMPROVEMENT IN SLEEP APNOEA OF ACROMEGALY AFTER SHORT-TERM TREATMENT WITH SOMATOSTATIN ANALOGUE SMS 201-995The Lancet, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- The Somatostatin Analog SMS 201-995 Induces Long-Acting Inhibition of Growth Hormone Secretion without Rebound Hypersecretion in Acromegalic Patients*Journal of Clinical Endocrinology & Metabolism, 1985
- Long term treatment of acromegaly with a long acting analogue of somatostatin.BMJ, 1985
- LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALYThe Lancet, 1984
- Dopaminergic Treatment of Acromegaly: Different Effects on Hormone Secretion and Tumor Size *Journal of Clinical Endocrinology & Metabolism, 1984
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effect of Somatostatin in Patients with AcromegalyNew England Journal of Medicine, 1974
- Growth Hormone Release Inhibiting Hormone in AcromegalyBMJ, 1974